V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10476989 | 10068262 | 1.65 | 78.8 | null | 2019-01-09 | 2019-01-27 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101589777 |
| 10477000 | 10068263 | 1.57 | 75.6 | Palliative (P) | 2020-07-05 | 2020-07-11 | Bendamustine+Rituximab(Sub Courses) | 02 | N | AVELUMAB | 100559763 |
| 10477078 | 10068264 | 1.83 | 70.9 | null | 2021-06-18 | 2021-06-18 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100335944 |
| 10477284 | 10068266 | 1.71 | 58.8 | null | 2018-11-19 | 2018-12-06 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100779797 |
| 10477406 | 10068267 | 1.73 | 88.9 | null | null | 2022-05-06 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100486177 |
| 10477780 | 10068268 | 1.82 | 70 | Palliative (P) | 2019-03-18 | 2019-03-24 | Venetoclax | 02 | N | VENETOCLAX | 101618022 |
| 10477990 | 10068269 | 1.6 | 66.3 | null | 2019-09-01 | 2019-09-01 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100880198 |
| 10478018 | 10068271 | 1.49 | 86.3 | null | 2020-06-01 | 2020-06-01 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101065849 |
| 10478099 | 10068272 | 1.62 | 61.4 | null | 2021-08-05 | 2021-08-12 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101248703 |
| 10478223 | 10068273 | 1.64 | 78.8 | null | 2019-10-01 | 2019-10-22 | Avelumab | 02 | null | AVELUMAB | 100055196 |
| 10478241 | 10068274 | 1.68 | 68.7 | null | 2021-05-26 | 2021-11-28 | Avelumab | 02 | null | NIVOLUMAB | 100094916 |
| 10478244 | 10068275 | 1.83 | 61 | null | 2021-03-11 | 2021-03-11 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101562540 |
| 10478268 | 10068276 | 1.7 | 73.4 | Palliative (P) | 2021-10-25 | 2021-10-25 | Oxaliplatin + Modified de Gramont | N | N | FLUOROURACIL + OXALIPLATIN | 101682411 |
| 10478666 | 10068280 | 1.63 | 77.4 | Disease modification (D) | 2020-03-22 | 2020-03-22 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100445526 |
| 10478886 | 10068282 | 1.83 | 0 | null | 2017-06-10 | 2017-07-08 | Avelumab | 02 | N | TRASTUZUMAB | 100964971 |
| 10478991 | 10068283 | 0 | 104.9 | Palliative (P) | 2020-01-26 | 2020-01-29 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100486701 |
| 10479247 | 10068284 | 1.66 | 93.9 | null | 2022-04-03 | 2022-05-02 | Avelumab | 02 | null | DARATUMUMAB | 101116360 |
| 10479274 | 10068285 | 0 | null | null | 2020-11-24 | 2020-12-08 | Avelumab | 02 | null | AVELUMAB | 101274669 |
| 10479358 | 10068286 | 1.65 | 54.95 | null | 2018-01-08 | 2018-01-15 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100276862 |
| 10479543 | 10068289 | null | 93.7 | null | 2019-03-02 | 2019-03-10 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100512914 |
| 10479792 | 10068290 | 1.49 | null | null | 2021-10-09 | 2021-10-10 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100215686 |
| 10479827 | 10068291 | 1.7 | 70 | Palliative (P) | null | 2021-11-17 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101459334 |
| 10479851 | 10068292 | 1.53 | null | null | 2021-10-22 | 2021-10-29 | Oxaliplatin + Modified de Gramont | null | null | FLUOROURACIL + OXALIPLATIN | 101838333 |
| 10479860 | 10068293 | 1.76 | 62 | Palliative (P) | 2017-12-03 | 2017-12-12 | Bendamustine+Rituximab (1st Course) | 02 | N | BENDAMUSTINE + RITUXIMAB | 101339784 |
| 10480208 | 10068294 | 1.56 | 76.9 | null | 2022-04-24 | 2022-05-04 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100621620 |
| 10480215 | 10068295 | 1.67 | 70.2 | null | 2020-03-20 | 2020-06-08 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100454175 |
| 10480357 | 10068296 | 1.62 | 59.7 | null | 2019-12-21 | 2020-01-13 | CEMIPLIMAB | null | null | CEMIPLIMAB | 101619979 |
| 10480360 | 10068297 | 1.76 | 0 | Palliative (P) | 2019-12-02 | 2019-12-24 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100916815 |
| 10480381 | 10068298 | 1.71 | 61.5 | null | null | 2020-11-02 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100301996 |
| 10480401 | 10068299 | 1.62 | 77.4 | null | 2020-12-13 | 2020-12-13 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101741382 |
| 10480411 | 10068300 | 1.59 | 106 | 03 | 2020-06-11 | 2020-06-11 | Avelumab | 02 | N | CAPECITABINE + OXALIPLATIN | 101360197 |
| 10480513 | 10068301 | 1.75 | 105 | null | 2020-04-23 | 2020-07-03 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100270357 |
| 10480527 | 10068302 | 1.85 | 75 | null | 2020-11-14 | 2021-02-14 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 100957815 |
| 10480569 | 10068303 | 1.72 | 68.2 | Palliative (P) | 2021-01-08 | 2021-06-12 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101368467 |
| 10480584 | 10068304 | 1.64 | 61 | null | 2021-03-15 | 2021-04-05 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 100826685 |
| 10480656 | 10068306 | 1.62 | 88.1 | null | 2019-06-05 | 2019-06-16 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100881397 |
| 10480685 | 10068307 | 1.75 | 45.8 | null | 2018-03-28 | 2018-03-29 | Venetoclax | 02 | null | VENETOCLAX | 101028572 |
| 10480829 | 10068309 | 1.72 | 60 | Neo-adjuvant (N) | 2020-12-14 | 2021-05-10 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100092207 |
| 10480863 | 10068310 | 1.83 | null | Palliative (P) | null | 2016-09-12 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 100610907 |
| 10480933 | 10068311 | 1.65 | 74.6 | 03 | null | 2020-06-06 | IRINOTECAN + MDG | 02 | N | FLUOROURACIL + IRINOTECAN | 101083981 |
| 10480995 | 10068313 | 1.71 | 82.3 | 03 | 2021-03-24 | 2021-04-14 | Avelumab | 02 | N | AVELUMAB | 101534738 |
| 10481125 | 10068314 | 1.77 | 60.5 | null | 2021-11-05 | 2021-11-05 | Avelumab | N | null | DARATUMUMAB | 100572122 |
| 10481225 | 10068315 | 1.74 | 76.6 | null | 2021-12-31 | 2022-01-28 | Avelumab | 02 | null | CEMIPLIMAB | 101223151 |
| 10481308 | 10068316 | 1.62 | 90 | null | null | 2019-11-20 | Venetoclax | 02 | null | VENETOCLAX | 101289950 |
| 10481594 | 10068318 | 1.9 | 74.2 | null | 2022-03-24 | 2022-04-10 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100636612 |
| 10481719 | 10068319 | 1.58 | 47 | Palliative (P) | 2017-12-16 | 2017-12-29 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100027387 |
| 10481992 | 10068320 | 1.74 | 102.2 | null | 2019-07-14 | 2019-07-17 | Avelumab | 01 | null | DARATUMUMAB | 100947385 |
| 10001985 | 10068322 | 1.62 | 75.5 | null | 2018-01-13 | 2018-01-22 | CEMIPLIMAB | N | null | CEMIPLIMAB | 101801414 |
| 10003300 | 10068323 | 1.75 | 104.9 | Palliative (P) | 2020-01-09 | 2021-08-26 | Avelumab | null | N | AVELUMAB | 101550335 |
| 10007087 | 10068325 | 1.54 | 80.1 | null | 2020-01-02 | 2020-02-06 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100256925 |